October 11-13, 2023
PACIFICO Yokohama, Japan
Booth #B-19
Resources
CPhI Barcelona 2023
October 24-26, 2023
Fira Barcelona
Booth #3D38
The benefits of CDMOs with customer-centric approaches and cohesive teams
In the highly competitive and rapidly evolving biopharma industry, choosing the right contract development and manufacturing organization (CDMO) is a critical decision that can significantly impact the success of a pharmaceutical development journey. When exploring potential CDMO partners, two key factors to consider are whether the company has a customer-centric approach, and if the team itself...
Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing
Taiwan, 31st July 2023: Bora Pharmaceuticals, a leading contract development and manufacturing organization (CDMO), is pleased to announce the opening of a new state-of-the-art facility in Taoyuan City, Taiwan. Officially opened by Bora Pharmaceuticals CEO Bobby Sheng and President of Taiwan Operations Tom Chang, the facility will provide Bora’s customers with access to an extensive range...